Chr. Olesen Synthesis

Hvidovre, Denmark
Hybrid — also manufactures internal programs
Small Molecule API
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ✓ Press (4) ✓ EMA GMP (6) ○ MHRA GMP ✓ HC GMP (1)

Quick Facts: Chr. Olesen Synthesis

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Hvidovre, Denmark
Website
Modalities
Small Molecule API
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Chr. Olesen Synthesis

Chr. Olesen Synthesis makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://cosynthesis.dk/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Chr. Olesen Synthesis FDA Inspection History

2023-11
NAI VAI OAI
Date Site Type Observations Classification
2023-11-22
Chr. Olesen Synthesis A/S
Hvidovre Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Chr. Olesen Synthesis EMA GMP Compliance 6 certificates

2023-11
2023-11
2021-02
2020-08
2019-09
2019-09
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
DK API-H 10000879 Chr. Olesen Synthesis A/S Denmark 2023-11-22 COMPLIANT
DK API-V 10000880 Chr. Olesen Synthesis A/S Denmark 2023-11-22 COMPLIANT
DK API-H 10000120 Chr. Olesen Synthesis A/S Denmark 2021-02-11 NON-COMPLIANT
DK API-H 00135920 Chr. Olesen Synthesis A/S Denmark 2020-08-27 COMPLIANT
DK API-H 00132120 Chr. Olesen Synthesis A/S Denmark 2019-09-26 COMPLIANT
DK API-V 00132120 Chr. Olesen Synthesis A/S Denmark 2019-09-26 COMPLIANT
Source: EMA EudraGMDP · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Company Signals 4 articles

Company announcements, not verified evidence. They do not change any score.
general 2026-10-02
Samfara completes acquisition of Chr. Olesen Synthesis, Danish manufacturer of controlled-substance APIs - PR Newswire
Samfara completes acquisition of Chr. Olesen Synthesis, Danish manufacturer of controlled-substance APIs  PR Newswire
ma 2026-10-02
Samfara Acquires Danish API Manufacturer Chr. Olesen Synthesis - citybiz
Samfara Acquires Danish API Manufacturer Chr. Olesen Synthesis  citybiz
ma 2026-10-02
Samfara buys Danish controlled-substance drug maker Chr. Olesen Synthesis - Dealroom
Samfara buys Danish controlled-substance drug maker Chr. Olesen Synthesis  Dealroom
ma 2026-10-02
Samfara Acquires Chr. Olesen Synthesis To Expand Controlled-Substance API Platform - Pulse 2.0
Samfara Acquires Chr. Olesen Synthesis To Expand Controlled-Substance API Platform  Pulse 2.0

Frequently Asked Questions About Chr. Olesen Synthesis

How many FDA inspections does Chr. Olesen Synthesis have on record?
CDMO Signal tracks 1 FDA inspection for Chr. Olesen Synthesis, sourced from the FDA inspection database. See the full inspection history above.
Has Chr. Olesen Synthesis received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Chr. Olesen Synthesis.
Does Chr. Olesen Synthesis hold EMA or MHRA GMP certificates?
CDMO Signal tracks 6 EMA GMP certificates for Chr. Olesen Synthesis.
Does Chr. Olesen Synthesis have a CDMO Signal Score?
Not yet. Chr. Olesen Synthesis is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Chr. Olesen Synthesis for a manufacturing program?
Use the free AI matchmaker to compare Chr. Olesen Synthesis against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Olon
Rodano (Milano), Italy
Small Molecule API, Biologics, ADC / Bioconjugation
Sterling Pharma Solutions
Cramlington, United Kingdom
Small Molecule API, High-Potency APIs, Peptides, ADC / Bioconjugation, Controlled Substances, Clinical Trial Manufacturing
Veranova
United States
Small Molecule API, ADC / Bioconjugation
Sai Life Sciences
India
Small Molecule API
EUROAPI
France
Small Molecule API, Oligonucleotide, Peptides, Lipids, Microbial Fermentation, Particle Engineering

Compare Chr. Olesen Synthesis with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Chr. Olesen Synthesis
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.